{"symbol":"ABBV","fiscalQuarter":"Q4-2013","reportDate":"2014-01-31","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2013","postBrief":{"headline":"AbbVie Misses on EPS, Stock Up 1.9%","keyNumbers":[{"metric":"EPS","actual":"$0.82","expected":"N/A","surprise":"-1.09%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We remain focused on our long-term growth strategy.","Our pipeline continues to show promise for future developments."],"summary":"Management expressed confidence in their long-term strategy despite the slight EPS miss. They highlighted the potential of their product pipeline."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"AbbVie's earnings report showed a slight miss on EPS, but the stock reacted positively, rising by 1.9%. Investors may have been encouraged by management's focus on long-term growth and the potential of their product pipeline, despite the lack of revenue data and guidance updates.","metaDescription":"AbbVie Inc (ABBV) Q4 2013 earnings: EPS missed expectations. Stock up 1.9%. Full breakdown."}}